Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis
media
posted on 2022-03-23, 10:49 authored by Roy M Fleischmann, Amy E Bock, Wuyan Zhang, Charles M Godfrey, Ivana Vranic, Carol Cronenberger, Eva DokoupilováThe above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2022.
